1001-5256
2013 Issue 9
Research advances in oxidative stress and mitochondrial permeability transition in liver failure
WANG Kefei;ZHU Yueke;MENG Qinghua
WANG Kefei;ZHU Yueke;MENG Qinghua
..............page:711-714
Fatality and adverse event rates of prostaglandin E in treating acute liver failure: a meta-analysis
chen xiao hong ; wu zong ying ; wang yi ping ; zeng chao ; pan tao
chen xiao hong ; wu zong ying ; wang yi ping ; zeng chao ; pan tao
..............page:681-684
Discontinuation of immunosuppressive therapy after liver transplantation: an analysis of one case
lv guo yue ; wang chuan lei ; sun xiao dong ; qiu wei ; du xiao hong ; zhang wei ; wang guang yi
lv guo yue ; wang chuan lei ; sun xiao dong ; qiu wei ; du xiao hong ; zhang wei ; wang guang yi
..............page:709-710
Clinical significance of α-fetoprotein in initial diagnosis of primary hepatic cancer
zhao chun hua ; zhou wen feng ; chen wei hua ; xi zuo ; zhang chun mei
zhao chun hua ; zhou wen feng ; chen wei hua ; xi zuo ; zhang chun mei
..............page:698-701
Clinical utility of hepatic venous pressure gradient for predicting outcome and guiding treatment of cirrhosis and portal hypertension
CAO Xunxun;LU Lungen
CAO Xunxun;LU Lungen
..............page:715-718
Acute-on-chronic liver failure: from pathophysiology to clinical practice
LI Junfeng;DUAN Zhongping
LI Junfeng;DUAN Zhongping
..............page:641-644
Determination of serum M30 and M65 levels and its clinical significance in patients with HBV-related acute-on-chronic liver failure
zhu bing ; you shao li ; wan zhi hong ; liu hong ling ; rong yi hui ; zuo hong ; zhang ai min ; xin shao jie
zhu bing ; you shao li ; wan zhi hong ; liu hong ling ; rong yi hui ; zuo hong ; zhang ai min ; xin shao jie
..............page:678-680
Progress in technology and clinical application of non-bioartificial liver support system
LIU Xiaohui;GUO Haiqing
LIU Xiaohui;GUO Haiqing
..............page:661-665
..............page:652-655
..............page:647-648
..............page:656-660
Therapeutic strategy for spontaneous rupture of primary hepatocellular carcinoma: report of 30 cases
wang yuan xi ; li zhi wei ; zheng yu ; chen jin ; zuo qing hua
wang yuan xi ; li zhi wei ; zheng yu ; chen jin ; zuo qing hua
..............page:695-697
..............page:649-651
Peroxisome proliferator-activated receptor gamma inhibits liver cancer proliferation and metastasis in vitro
SHEN Bo;NIE Yuqiang
SHEN Bo;NIE Yuqiang
..............page:702-706
Advances in treatment of primary biliary cirrhosis
QIN Hua;BAI Shishan
QIN Hua;BAI Shishan
..............page:719-721
..............page:689-691
Case of subacute liver failure due to hyperthyroidism
jing zuo ; luo sheng qiang ; gong ; sun yong qiang ; zhang fan ; zhang ning ; wu xin ; liu hong hong
jing zuo ; luo sheng qiang ; gong ; sun yong qiang ; zhang fan ; zhang ning ; wu xin ; liu hong hong
..............page:707-708
Risk factors, diagnostic criteria, and drug discontinuation criteria for drug-induced liver injury
YU Zheng;JIA Jidong
YU Zheng;JIA Jidong
..............page:674-677
..............page:645-646
Causes and countermeasures of delayed hemobilia after endoscopic retrograde cholangiopancreatography
WANG Jiheng;GAO Ge;SHI Jiujian
WANG Jiheng;GAO Ge;SHI Jiujian
..............page:692-694
..............page:666-669
Preliminary investigation of hybrid bioartificial liver support system in treatment of HBV-related acute-on-chronic liver failure
you shao li ; liu hong ling ; rong yi hui ; zhu bing ; zuo hong ; liu wan zuo ; wan zhi hong ; mao pan yong ; xin shao jie
you shao li ; liu hong ling ; rong yi hui ; zhu bing ; zuo hong ; liu wan zuo ; wan zhi hong ; mao pan yong ; xin shao jie
..............page:685-688
Investigation of artificial liver support system combined with stem cell transplantation in treatment of liver failure
HE Hongliang;LI Jianguo;GAO Zhiliang
HE Hongliang;LI Jianguo;GAO Zhiliang
..............page:670-673